LPIN2

protein-coding

lipin 2, the group of Lipins

Gene summary

Mouse studies suggest that this gene functions during normal adipose tissue development and may play a role in human triglyceride metabolism. This gene represents a candidate gene for human lipodystrophy, characterized by loss of body fat, fatty liver, hypertriglyceridemia, and insulin resistance. [provided by RefSeq, Jul 2008]

MANE transcript

NM_001375808.2

Inheritance

AR

ClinVar variants

P:49U:354B:233

Top phenotype

Majeed syndrome

gnomAD constraint

pLI —, LoF o/e 0.34

Max pathogenic AF

—

Genomic locus

chr18:2,885,296-3,013,144

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~127.8 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

Majeed syndromeSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0012316

Submitter: Labcorp Genetics (formerly Invitae)

Majeed syndromeDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0012316

Submitter: ClinGen

LPIN2 was first reported in relation to autosomal recessive Majeed syndrome in 2005 (Ferguson PJ et al., PMID: 15994876). The syndrome of pediatric-onset congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis was first described in 1989, along with its association with Sweet’s syndrome (Majeed HA et al., PMID: 2809904). Over the years, case reports have expanded the phenotype to include recurrent fevers, elevated acute phase reactants and hepatosplenomegaly. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism, inheritance pattern, nor phenotypic variability. Therefore, the following disease entities have been lumped into one disease, Majeed syndrome (OMIM:609682). Ten variants (missense, nonsense, and splice site) that have been reported in 7 probands in 5 publications (PMIDs: 33993107, 15994876, 37865862, 27252506, 17330256) are included in this curation. Functional data exists that confirms, p.Ser734Leu, leads to impaired protein function via loss of phosphatidic acid phosphatase activity (PMID:197717560). All probands are homozygous and none are known to be de novo. ClinVar reports at total of 37 P/LP variants which include frameshift, large deletion, and compound heterozygous variants (Bhuyan et al., PMID 33314777) but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss of inhibition. This gene-disease relationship is also supported by in vitro functional assays and cell culture models (PMIDs: 28031477,33314777). Lipin-2 inhibits activation and sensitization of P2X7R, thereby regulating NLRP3 inflammasome assembly. Deficient macrophages have low intracellular cholesterol levels which alter ion currents through the P2X7R. These currents are corrected when cholesterol levels are restored in concordance with decreased inflammasome activation. Patient cells and LPIN2 deficient macrophages demonstrate increased IL-1B expression, caspase 1 activation, and osteoclastogenesis. Pit assays with patient cells demonstrate increased bone resorption. In summary, there is definitive evidence supporting the relationship between LPIN2 and autosomal recessive Majeed Syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Monogenic Autoinflammatory Disease GCEP on the meeting date May 15, 2024. (SOP Version [10])].

Majeed syndromeSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0012316

Submitter: PanelApp Australia

Majeed syndromeSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0012316

Submitter: Orphanet

Clinical Genomic Database (CGD)

Majeed syndromeAR

Manifestation: Allergy/Immunology/Infectious; Dermatologic; Hematologic

Intervention: Allergy/Immunology/Infectious; Hematologic

Rationale: Individuals may manifest with Chronic recurrent multifocal osteomyelitis (CRMO), for which treatment with NSAIDs/corticosteroids may be beneficial; Individuals may require surveillance and blood transfusion treatment for anemia

Refs: 11381255; 17011878; 17330256; 18055821; 20301735; 22559933; 22570351Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to LPIN2 variants in ClinVar

9 Conditions Cataloged
Majeed syndromeTotal: 714
not providedTotal: 172
not specifiedTotal: 122
Inborn genetic diseasesTotal: 104
Autoinflammatory syndromeTotal: 78
LPIN2-related disorderTotal: 30
LPIN2-related disordersTotal: 7
PsoriasisTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001375808.2. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
11
clinvar
209
clinvar
220
missense
2
clinvar
335
clinvar
22
clinvar
1
clinvar
360
nonsense
7
clinvar
3
clinvar
4
clinvar
14
start loss
0
frameshift
15
clinvar
6
clinvar
1
clinvar
22
splice donor/acceptor (+/-2bp)
1
clinvar
15
clinvar
3
clinvar
1
clinvar
20
Total23263542321636

Highest pathogenic variant AF is 0.000022582075

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 34 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001375808.2RefSeqNP_001362737.119MANE Select
ENST00000677752.1EnsemblENSP00000504857.119MANE Select
NM_001375809.1RefSeqNP_001362738.119Standard
NM_014646.2RefSeqNP_055461.119Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Glycerolipid metabolism - Homo sapiens (human)
  • Glycerophospholipid metabolism - Homo sapiens (human)
  • Adipogenesis
  • Metabolism of lipids
  • Metabolism

Biological Process

  • lipid metabolic process
  • phosphatidylethanolamine biosynthetic process
  • phosphatidylcholine biosynthetic process
  • fatty acid catabolic process
  • dephosphorylation

Molecular Function

  • transcription coactivator activity
  • phosphatidate phosphatase activity

Cellular Component

  • nucleus
  • endoplasmic reticulum membrane
  • cytosol

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000261596
Coding exons
19
Length
96322
Individuals with no LoFs
125686
Homozygous LoFs
0
Heterozygous LoFs
62
Defined
125748
p
0.000247
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.9834314920.8750.00002835883
Missense (PolyPhen)139223.790.621132696
Synonymous-1.142151951.100.00001331700
Loss of Function4.331750.00.3400.00000287579

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000310.00031rare
Latino/Admixed American0.000170.00017rare
Ashkenazi Jewish0.00140.0014notable
East Asian0.000160.00016rare
Finnish0.0000470.000046rare
European (Non-Finnish)0.000230.00023rare
South Asian0.000130.00013rare
Other0.000490.00049rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Plays important roles in controlling the metabolism of fatty acids at different levels. Acts as a magnesium-dependent phosphatidate phosphatase enzyme which catalyzes the conversion of phosphatidic acid to diacylglycerol during triglyceride, phosphatidylcholine and phosphatidylethanolamine biosynthesis in the reticulum endoplasmic membrane. Acts also as a nuclear transcriptional coactivator for PPARGC1A to modulate lipid metabolism (By similarity). {ECO:0000250}.;
Disease
DISEASE: Majeed syndrome (MJDS) [MIM:609628]: An autosomal recessive syndrome characterized by chronic recurrent multifocal osteomyelitis that is of early onset with a lifelong course, congenital dyserythropoietic anemia that presents as hypochromic, microcytic anemia during the first year of life and ranges from mild to transfusion-dependent, and transient inflammatory dermatosis, often manifesting as Sweet syndrome (neutrophilic skin infiltration). {ECO:0000269|PubMed:15994876}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.155

Intolerance Scores

LoFtool
0.319
RVIS EVS
-0.79
RVIS percentile EVS
12.57

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.261

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.